Format

Send to

Choose Destination
ACS Chem Biol. 2017 Mar 17;12(3):628-634. doi: 10.1021/acschembio.6b01002. Epub 2017 Jan 19.

An Engineered Allele of afsQ1 Facilitates the Discovery and Investigation of Cryptic Natural Products.

Author information

1
Department of Biochemistry, University of Toronto , MaRS Centre - West Tower, 661 University Avenue, Toronto, Ontario M5G 1M1, Canada.
2
Department of Biology, McMaster University , 1280 Main Street W, Hamilton, Ontario L8S 4K1, Canada.
3
Michael G. DeGroote Institute for Infectious Disease Research, McMaster University , 1280 Main St W., Hamilton, Ontario L8S 4K1, Canada.

Abstract

New approaches to antimicrobial discovery are needed to address the growing threat of antibiotic resistance. The Streptomyces genus, a proven source of antibiotics, is recognized as having a large reservoir of untapped secondary metabolic genes, many of which are likely to produce uncharacterized compounds. However, most of these compounds are currently inaccessible, as they are not expressed under standard laboratory conditions. Here, we present a novel methodology for activating these "cryptic" metabolites by heterologously expressing a constitutively active pleiotropic regulator. By screening wild Streptomyces isolates, we identified the antibiotic siamycin-I, a lasso peptide that we show is active against multidrug pathogens. We further revealed that siamycin-I interferes with cell wall integrity via lipid II. This new technology has the potential to be broadly applied for use in the discovery of additional "cryptic" metabolites.

PMID:
28075554
DOI:
10.1021/acschembio.6b01002
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for American Chemical Society
Loading ...
Support Center